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ABSTRACT 38 
Background: Hip fractures are associated with diminished quality of life and survival 39 
especially amongst the elderly.  40 
Objective: All-cause mortality after hip fracture was investigated to assess its 41 
magnitude.  42 
Methods: A total of 122,808 participants from 8 cohorts in Europe and USA were 43 
followed-up for a mean of 12.6 years, accumulating 4,273 incident hip fractures and 44 
27,999 deaths. Incident hip fractures were assessed through telephone 45 
interviews/questionnaires or national inpatient/fracture registries and causes of death 46 
were verified with death certificates. Cox proportional hazards models and the time-47 
dependent variable methodology were used in order to assess the association between 48 
hip fracture and mortality and its magnitude at different time intervals after the injury 49 
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in each cohort. We obtained the effect estimates through a random-effects meta-50 
analysis. 51 
Results: Hip fracture was positively associated with increased all-cause mortality; the 52 
hazard ratio (HR) in the fully adjusted model was 2.12, 95% confidence interval (CI) 53 
1.76-2.57, after adjusting for potential confounders. This association was stronger 54 
among men [HR:2.39, 95% CI:1.72-3.31] than among women [HR:1.92, 95% 55 
CI:1.54-2.39], although this difference was not significant. Mortality was higher 56 
during the first year after the hip fracture [HR:2.78, 95% CI:2.12-3.64] but it 57 
remained elevated without major fluctuations after longer time since hip fracture [HR 58 
(95% CI): 1.89 (1.50-2.37) after 1-4 years; 2.15 (1.81-2.55) after 4-8 years; 1.79 59 
(1.57-2.05) after 8 or more years]. 60 
Conclusion: In this large population-based sample of older persons across 8 cohorts, 61 
hip fracture was associated with excess short and long-term all-cause mortality in both 62 
sexes.   63 
 64 
 65 
Introduction  66 
As the population ages, bone fractures are becoming an increasingly important health 67 
problem among the elderly with substantial burden for the individual and society. Hip 68 
fractures are the most relevant fractures in terms of severity, functional dependence, 69 
social and economic cost and fatality [1–3].  70 
 71 
Despite a well-known increase in mortality shortly after hip fracture [3–5], the 72 
evidence on the long-term mortality following a hip fracture is not consistent [6–11]. 73 
Some studies have demonstrated a persistent increase in all-cause mortality in the 74 
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long term after the injury [6–9], whereas others report from low to no elevated long 75 
term mortality after hip fracture [10, 11]. The higher mortality rates were mostly 76 
observed in elderly, ill or impaired populations [6, 7]. A recent meta-analysis 77 
exploring the magnitude and duration of excess mortality risk after hip fracture found 78 
the highest risk in the first 3 months after the fracture (5- to 8-fold increase), and 79 
mortality remained elevated, compared to age-matched controls, even after 10 years. 80 
The excess risk increased with age and, at any given age, was higher for men than for 81 
women [12]. 82 
 83 
The aim of the present study was to investigate both short- and long-term mortality 84 
after hip fracture in a large cohort of community dwellers, aged 60 years and older, 85 
from Europe and the USA who were followed up prospectively.  86 
 87 
 88 
 89 
 90 
 91 
Materials and methods  92 
The CHANCES project  93 
The Consortium on Health and Ageing: Network of Cohorts in Europe and United 94 
States (CHANCES) project is a large collaboration, funded by the European 95 
Commission within the Seventh Framework Programme, combining 14 major 96 
cohorts/studies from Europe and the USA, in order to provide evidence on ageing-97 
related health characteristics and determinants of healthy ageing. The study protocol 98 
of each individual cohort/study has been approved by local ethics committees and all 99 
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participants have given written informed consent before enrolment. All procedures 100 
have been carried out in accordance with the Declaration of Helsinki. Variables 101 
harmonized across the cohorts were created following predetermined standardized 102 
procedures. The study design and population characteristics of the cohorts included in 103 
the CHANCES project have been described in detail elsewhere [13]. 104 
 105 
Eight cohorts with available information on hip fractures during follow-up as well as 106 
mortality were included in the present analysis: EPIC-Elderly Greece and EPIC-107 
Elderly Umea, Sweden [14]; the ESTHER (Epidemiological Study on the Chances of 108 
Prevention, Early Recognition and Optimised Treatment of Chronic Diseases in the 109 
Older Population) Study from Germany [15]; the Tromsø study from Norway [16]; 110 
the Swedish Mammography Cohort (SMC) and the Cohort Of Swedish Men (COSM) 111 
studies [17]; the Nurses' Health Study (NHS) from the USA [18] and the Health, 112 
Alcohol and Psychosocial factors in Eastern Europe (HAPPIE) study with data from 113 
the Czech Republic [19]. Further details about the participating cohorts are available 114 
in the Αppendix. 115 
 116 
Information on incident hip fractures 117 
Information on incident hip fractures was collected through telephone interviews or 118 
questionnaires to elicit self-reported data in EPIC-Elderly Greece, ESTHER and NHS 119 
and through national inpatient registries or fracture registries in EPIC-Elderly Umea, 120 
the Tromsø study, COSM, SMC and the Czech HAPIEE cohort [16, 20]. In order to 121 
verify self-reported hip fractures, validation studies were conducted for EPIC-Elderly 122 
Greece and ESTHER in the context of the CHANCES project. The rate of verification 123 
ranged from 52% to 86%. A validation study was also conducted as part of the NHS 124 
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in which all self-reported hip fractures were confirmed by medical records [21], while 125 
COSM, SMC and the Tromsø study had shown high validity of incident hip fracture 126 
diagnosis using the Swedish National Inpatient Register [20, 22]. Hip fractures 127 
identified as International Classification of Diseases and Related Health Problems 10th 128 
Revision (ICD-10) codes S72.0–S72.2 were included in the analyses.  129 
 130 
Information on all-cause mortality  131 
Vital status of the participants was assessed either by contacting relatives or 132 
household members, or through record linkage with nationwide or local death 133 
registries. All causes of death were verified through death certificates, whereas ICD 134 
coding was used across the cohorts.  135 
 136 
Statistical analysis 137 
Individual cohorts. In order to describe the socioeconomic, lifestyle, medical and 138 
anthropometric characteristics of the participants, the distribution of the 139 
corresponding variables, separately for men and women in every cohort, is presented. 140 
Cox regression was applied for the cohort-specific analyses to calculate hazard ratios 141 
(HRs) and 95% confidence intervals (95% CIs) for mortality following the occurrence 142 
of a hip fracture event. The survival time was calculated from the date of enrolment in 143 
the study until the date of death (for those who died during follow-up) or the date of 144 
last follow-up (for those who were alive at that time). Once the exposure of interest in 145 
this study was the hip fracture event, which occurred during follow-up, we treated hip 146 
fracture as a time-dependent variable in order to capture the association between hip 147 
fracture and mortality. The same methodology was used in order to assess the 148 
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aforementioned association at different time intervals from the beginning of the hip 149 
fracture event.  150 
 151 
Models were run with three levels of adjustment with an increasing number of 152 
confounders. Specifically, model 1 was only adjusted for age (in years; continuous 153 
variable) and sex. Model 2 was additionally adjusted for the continuous variables 154 
body mass index (BMI) (in kg/m2), height (in m), daily energy intake (in kcal/day) 155 
and alcohol intake (in g/day) and the categorical variables vigorous physical activity 156 
(yes/no), educational level (none/less than primary/vocational or technical 157 
secondary/secondary, not vocational and not technical/college or university), living 158 
alone (yes; for single, widowed, separated or divorced/ no; for married or living 159 
together), employment status (full-time or part-time employment and not of 160 
pensionable age/self-employment/housewife and not of pensionable age/pensionable 161 
age and still working/pensionable age and not working/stopped working before 162 
retirement age due to poor health/unemployed and not of pensionable age) and 163 
smoking status (never/former/current smoker). Finally, model 3 was additionally 164 
adjusted for hypertension (yes/no) and chronic diseases (cardiovascular disease, 165 
diabetes or cancer; yes/no).  166 
After following a consistent harmonization procedure [13], minor differences in the 167 
definition of variables used were observed, whereas the variables that were not 168 
common in all cohorts and were used later in our analysis are the following: alcohol 169 
intake (many missing values in the Tromsø study), energy intake (not available in the 170 
Tromsø study and ESTHER), education (all participants in NHS educated to the same 171 
level), prevalent cancers (excluded in COSM at baseline), living alone (not available 172 
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in SMC), vigorous physical activity (not available in EPIC-Sweden) and prevalent hip 173 
fractures (not available in EPIC-Greece and EPIC-Sweden). 174 
 175 
Participants aged ≥60 years at enrolment without a prevalent hip fracture event were 176 
included in the present analysis. Model 3 was chosen as the main (fully adjusted) 177 
model. We excluded from our analyses those participants without information either 178 
during follow-up or in this model's variables. We performed three further subanalyses 179 
restricted to (i) men, (ii) women and (iii) subjects aged ≥70 years at enrolment. 180 
 181 
We also tried to assess interaction on an additive scale between hip fractures and other 182 
risk factors using the relative excess risk due to interaction (RERI) index [23]: 183 
RERI= (λ11 - λ10 - λ01 + λ00)/λ00, where 184 
λ11=hazard rate when hip fracture and the other risk factor are present; 185 
λ10=hazard rate when hip fracture is present and the other risk factor is absent; 186 
λ01=hazard rate when hip fracture is absent and the other risk factor is present; 187 
λ00=hazard rate when hip fracture and the other risk factor are absent. 188 
 189 
In other words: 190 
RERI=HR11 - HR10 - HR01 + 1, where 191 
HR11=hazard ratio when hip fracture and the other risk factor are present; 192 
HR10=hazard ratio when hip fracture is present and the other risk factor is absent; 193 
HR01=hazard ratio when hip fracture is absent and the other risk factor is present. 194 
All cohort-specific analyses were carried out using Stata statistical software versions 195 
10–13 (STATA Corp LP).  196 
 197 
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Meta-analysis. All meta-analyses of cohort-specific estimates were performed using 198 
the DerSimonian–Laird method with random effects [24]. We estimated the HRs and 199 
95% CIs for mortality following hip fracture events, after combining all results from 200 
each cohort separately. The heterogeneity between cohorts was measured using the I² 201 
statistic and tested for statistical significance with the chi-squared test from Cochran’s 202 
Q statistic [25]. Moreover, we tested effect modification with a meta-analysis of all 203 
available estimates from different strata by calculating the chi-squared test for 204 
heterogeneity. 205 
For the meta-analysis of interaction on an additive scale, we applied the index-based 206 
approach for meta-analyses; that is, we calculated the RERI (index of interest) in all 207 
cohorts and then performed a meta-analysis including these indices. 208 
 209 
For all meta-analyses we used Stata, version 11. All tests were two-sided and P-210 
values less than 0.05 were considered statistically significant. 211 
 212 
Results 213 
The study population consisted of 122,808 participants from eight cohorts (seven 214 
from Europe and one from the USA); during a mean follow-up time of 12.6 years 215 
(range 7.9–13.7 years) there were 4273 incident hip fractures. Participants were 216 
mostly recruited during the 1990s, and a total of 27,999 participants died during 217 
follow-up (Table 1). The rate of hip fracture varied from 1.2% to 10.3%. Once all 218 
participants were at least 60 years old, small age differences were observed among the 219 
cohorts. The percentage of participants with one or more missing values for any of the 220 
variables included in the analysis varied from 8% to 44% across the cohorts; however, 221 
the distribution of the variables in each cohort before and after exclusions were 222 
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essentially the same (see Online Resource 1). The baseline characteristics of the study 223 
participants are presented by sex and cohort in Tables 2A and 2B.  224 
 225 
Table 3 and Fig. 1 show that the occurrence of hip fracture was positively associated 226 
with all-cause mortality (in model 3: HR 2.12, 95% CI 1.76–2.57) after adjusting for 227 
all available potential confounders. After excluding HAPIEE from the analysis due to 228 
the exceptionally high HR, overall associations decreased but remained statistically 229 
significant (in model 3: HR 1.98, 95% CI 1.65–2.38). The association between hip 230 
fracture and mortality slightly decreased after adjusting for increasing number of 231 
confounders (i.e. from model 1 to model 3). Model 3 showed that this relationship 232 
was somewhat stronger among men (HR 2.39, 95% CI 1.72–3.31) than women (HR 233 
1.92 (95% CI 1.54–2.39), and was weaker but still significant among participants 234 
aged ≥70 years old (HR 1.84, 95% CI 1.46–2.33), as the underlying risk of these 235 
(more elderly) participants is higher. When a sensitivity analysis was applied 236 
restricting the analysis to cohorts that included both sexes, the differences remained 237 
largely unchanged and statistically significant (in model 3: HR 2.37 and 1.94 for men 238 
and women respectively). By contrast, when the association among participants aged 239 
≥70 years was compared with the association in the primary analysis of participants 240 
≥60 years, after excluding EPIC-Sweden, NHS and HAPIEE which do not contribute 241 
to the HR of subjects aged ≥70 years old (because they have very few or no 242 
participants in this age group at baseline), the difference was small [in model 3: HR  243 
1.91 and 1.84 for all participants (≥60 years old) and those ≥70 years old 244 
respectively]. Although the heterogeneity of the associations was high in all these 245 
comparisons (in general: 70% ≤ I ≤ 90%), the relationship between hip fracture and 246 
mortality was positive in all countries, but differed in magnitude (Fig. 1).  247 
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 248 
Although the proportionality assumption was not violated in any of the cohorts, we 249 
also estimated the time-dependent effect of hip fracture on mortality (Τable 4). We 250 
found that the short-term effect of hip fractures was higher than the mid- and long-251 
term effects. Specifically, the HR in the first year after hip fracture was 2.78 (95% CI 252 
2.12–3.64), whereas in the longer term hip fractures were associated with an almost 2-253 
fold increase in mortality (1–4 years after hip fracture: HR 1.89, 95% CI 1.50–2.37; 254 
4–8 years after hip fracture: HR 2.15, 95% CI 1.81–2.55; and ≥8 years after hip 255 
fracture: HR 1.79, 95% CI 1.57–2.05). In this time-dependent analysis, we considered 256 
the effects of all cohorts for all time periods (except HAPIEE, which does not 257 
contribute to the overall HR for ≥8 years). However, the conclusions were unchanged 258 
when we excluded the HAPIEE cohort from this analysis (data not shown).  259 
 260 
Finally, we found that the associations between the combination of hip fracture and 261 
prevalent chronic disease and mortality were super-additive (RERI >0), as evidenced 262 
by a 42% (95% CI 10–75%) excess risk of mortality due to the joint presence of hip 263 
fracture and chronic disease (Fig. 2). When we investigated any possible excess risk 264 
due to the interaction between hip fracture and obesity and living alone, we found no 265 
significant deviation from additivity. 266 
 267 
Discussion 268 
In this large sample of individuals, aged 60 years and older from Europe and the 269 
USA, there was evidence that hip fracture is associated with excess short- and long-270 
term all-cause mortality in both sexes. Participants who had experienced a hip fracture 271 
during follow-up had the highest risk of dying during the first year after the fracture, 272 
12 
 
and an almost 2-fold increase in mortality persisted even 8 years or more after the 273 
injury. Small differences were observed according to sex, with the magnitude of the 274 
increase in all-cause mortality somewhat larger among men. Associations were 275 
significant even after controlling for chronic comorbidities and lifestyle factors. 276 
Furthermore, prevalence of chronic diseases at baseline was found to have a super-277 
additive effect with hip fractures on mortality (as tested using the RERI index), 278 
implying that individuals with chronic diseases need particularly careful management 279 
following a hip fracture.  280 
 281 
Our results with respect to short-term excess all-cause mortality confirm those of 282 
other studies and the most recent meta-analysis (almost 3-fold increase in the present 283 
study compared to 3- to 5-fold increase during the first 6 months in the recent meta-284 
analysis) [5, 9, 12]. To the best of our knowledge, excess short-term mortality 285 
following hip fracture, especially during the first 3–6 months, was observed in all 286 
previously published studies. Factors that contribute the most to this finding are 287 
linked to postoperative complications after surgery such as cardiac and pulmonary 288 
complications, infections (i.e. pneumonia and septicaemia) and increased risk of 289 
thromboembolism [26, 27]. Other factors, such as multiple comorbid conditions have 290 
also been implicated [12, 25]. 291 
 292 
A difference in excess all-cause mortality after hip fracture among men and women, 293 
and specifically a higher excess mortality among men, although minimal in this study, 294 
has been a consistent finding in previous studies [5, 12, 27–29]. It seems that although 295 
hip fracture incidence in men is substantially lower compared to women, mortality 296 
after hip fracture is higher in men [29]. Efforts to explore further the causes of this 297 
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gender difference have shown, in most instances, that such differences remained even 298 
after controlling for chronic comorbidities and medications [28].  299 
 300 
Long-term mortality after hip fracture was significantly elevated, not only for the first 301 
8 years, but also after that period. The excess long-term risk of death after hip fracture 302 
has been found in the majority but not all relevant studies, however the mechanisms 303 
underlying this excess risk remain unclear [6–11]. One explanation has been the co-304 
existence of chronic disease, but excess mortality remained in the studies that 305 
collected and had the ability to adjust for such data [4, 6, 7, 12]. On the other hand, 306 
hip fracture is associated with increased functional decline and disability in the elderly 307 
[30]. Recently, hip fracture occurrence has also been associated with an exaggerated 308 
persistent inflammatory response, while, in parallel, chronic inflammation might play 309 
a role in the functional decline and the onset or acceleration of frailty [31–33]. These 310 
mechanisms could provide a possible explanation of the observed decline in health 311 
and the increased long-term mortality after hip fracture. In addition, the detrimental 312 
effect of long-standing pain and diminished quality of life, especially when followed 313 
by loss of independence, should not be underestimated [34].  314 
 315 
The strengths of our study include the large, population-based sample of more than 316 
100,000 elderly participants from Europe and the USA, the prospective design, the 317 
use of harmonized variables across the cohorts and the implementation of a common 318 
statistical analysis with individual data. The analysis of harmonized individual data 319 
possibly reduced the potential heterogeneity, which generally occurs when performing 320 
a meta-analysis of published data. Moreover, by analysing results from different 321 
cohorts without knowing a priori the associations that would be estimated, we have 322 
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overcome the problem of publication bias [35] that may be present in other meta-323 
analyses of previous publications [12].  324 
 325 
A limitation of this study is the different periods of enrolment of the participants in 326 
the cohorts as both life expectancy and some aspects of hip fracture treatment have 327 
changed during these years. Although the majority of participants entered the studies 328 
during the 1990s, subjects were also recruited during the late 1980s to the NHS and 329 
during the 2000s to the NHS, ESTHER and HAPIEE-Czech. Nevertheless, although 330 
heterogeneity was observed between cohorts (perhaps partially explained by the 331 
different periods of recruitment of the participants in the cohorts along with the fact 332 
that participants had different characteristics across cohorts; see Tables 1, 2A and 2B), 333 
the association between hip fracture and subsequent mortality, showed the same 334 
positive direction in all cohorts. Moreover, heterogeneity decreased according to the 335 
period after hip fracture, possibly due to the decreased number of events (deaths) over 336 
time. Furthermore, we could not determine the cause of hip fracture; more 337 
specifically, we were not able to differentiate between high-energy (e.g. traffic 338 
accidents) and low-energy trauma (e.g. falls from standing height), although the 339 
majority of hip fractures in older subjects (≥60 years of age) are low-energy fractures. 340 
The different methods of hip fracture and mortality ascertainment used across the 341 
participating cohorts could potentially have resulted in differing degrees of under- and 342 
over-reporting of hip fracture cases and deaths that could further influence the 343 
association under study. Also, although extensive harmonization was undertaken in 344 
the context of the CHANCES project, different methods of data collection were used, 345 
and not all covariates were assessed in all cohorts. Residual confounding may also 346 
exist because of the inability to control for other parameters such as medication (e.g. 347 
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bisphosphonates), supplement use and access to healthcare across the cohorts. 348 
Additionally, covariates such as BMI, alcohol intake, physical activity and 349 
comorbidities were assessed at baseline and not updated during follow-up. It is 350 
unlikely, however, that such changes in the covariates would have had a major impact 351 
on the results. Information on nursing home status at the time of hip fracture was not 352 
available and thus we could not differentiate between nursing home residents and 353 
community-dwelling participants in our analyses. Nursing home residents have been 354 
shown to experience higher mortality in comparison to community dwellers both 355 
among individuals with hip fracture, especially in the immediate post-injury period, 356 
and among those without hip fracture [36]. The magnitude of missing data could have 357 
affected our findings. However, the extent would be small as there was no significant 358 
difference in the characteristics of the available participants and of those included in 359 
the analysis (see Online Resource 1). Finally, the findings of this study cannot be 360 
extrapolated to populations other than white men and women aged ≥60 years with 361 
similar sociodemographic characteristics to those of the study participants.      362 
 363 
Conclusions 364 
In conclusion, our study confirms that elderly individuals who have suffered a hip 365 
fracture are at increased risk of dying, compared to those who have not, in the short 366 
term after the fracture but also years later. Appropriate measures need to be 367 
implemented for primary and secondary prevention of hip fracture in order to ensure 368 
better quality of life and survival in the elderly.      369 
 370 
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APPENDIX 
The participating cohorts 
EPIC–Elderly (European Prospective Investigation into Cancer and Nutrition) 
EPIC-Elderly cohort consists of approximately 100000 participants (aged 60 years 
and older at recruitment) recruited initially in the EPIC Study [1]. EPIC is an on–
going, multi–centre, prospective cohort study aiming to investigate the role of 
biological, dietary, lifestyle, and environmental factors in the aetiology of cancer and 
other chronic diseases. Twenty three research centres from 10 European countries 
participate in EPIC (Denmark, France, Germany, Greece, Italy, the Netherlands, 
Norway, Spain, Sweden, and the United Kingdom). Recruitment took place from 
1992 to 2000 via administration of baseline questionnaires and interviews. After 
enrolment, participants were followed–up at regular intervals every 3–4 years [2]. 
EPIC-GREECE 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
Continuous variables 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 9818 29.3 4.6 
Height (m) 9826 1.58 0.09 
Alcohol intake (gr/d) 9838 7.5 16.3 
Energy intake (Kcal/d) 9838 1806.4 584.5 
Age at recruitment (years) 9863 67.3 4.5 
Age at exit from follow-up (years) 9863 77.3 5.2 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 9037 29.3 4.6 
Height (m) 9037 1.58 0.09 
Alcohol intake (gr/d) 9037 7.5 16.4 
Energy intake (Kcal/d) 9037 1805.5 580.7 
Age at recruitment (years) 9037 67.3 4.5 
Age at exit from follow-up (years) 9037 77.6 4.9 
 
 
 
 
 
 
 
 
 
Categorical variables 
 
Descriptive statistics for categorical variables (overall) 
 
  all 
excluding 
missing 
 
  
 
n %   n % 
Vigorous 
Physical  no 
 
7678 79.3 
 
7172 79.4 
activity yes 
 
2008 20.7 
 
1865 20.6 
Education none or less than primary 
 
4765 48.6 
 
4404 48.7 
 
primary 
 
4179 42.7 
 
3869 42.8 
 
vocational or technical secondary 
 
78 0.8 
 
66 0.7 
 
secondary not vocational/technical 
 
469 4.8 
 
423 4.7 
  college or university 
 
306 3.1 
 
275 3.0 
Living alone no 
 
7815 79.5 
 
7207 79.7 
 
yes 
 
2016 20.5 
 
1830 20.3 
Employment  employed, not of pensionable age 
 
1804 18.4 
 
1649 18.2 
status self-employed 
 
0 0.0 
 
0 0.0 
 
housewife  
 
2793 28.4 
 
2583 28.6 
 
pensionable age, working 
 
0 0.0 
 
0 0.0 
 
pensionable age, not working 
 
5169 52.6 
 
4742 52.5 
 
not working due to poor health 
 
0 0.0 
 
0 0.0 
  unemployed-not of pensionable age 
 
65 0.7 
 
63 0.7 
Smoking  never 
 
6658 69.5 
 
6282 69.5 
status former 
 
1781 18.6 
 
1687 18.7 
 
current 
 
1134 11.8 
 
1068 11.8 
Hypertension no 
 
5361 54.4 
 
4895 54.2 
  yes 
 
4502 45.6 
 
4142 45.8 
Prevalent  no 
 
9521 96.5 
 
8717 96.5 
cancer yes 
 
342 3.5 
 
320 3.5 
Prevalent no 
 
8403 85.5 
 
7720 85.4 
diabetes yes 
 
1420 14.5 
 
1317 14.6 
Prevalent no 
 
9230 93.6 
 
8444 93.4 
cvd yes 
 
633 6.4 
 
593 6.6 
Mortality alive 
 
7844 79.5 
 
7130 78.9 
Status dead 
 
2019 20.5 
 
1907 21.1 
Incident Hip  no  
9647 97.8 
 
8828 97.7 
Fractures yes  
216 2.2 
 
209 2.3 
 
 
 
 
 
 
 
EPIC - SWEDEN 
 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
 
Continuous variables 
 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 3344 25.9 4.1 
Height (m) 3351 1.68 0.09 
Alcohol intake (gr/d) 3364 2.8 4.1 
Energy intake (Kcal/d) 3364 1635.9 592.3 
Age at recruitment (years) 3364 60.4 1.2 
Age at exit from follow-up (years) 3364 73.6 3.1 
 
 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 3108 25.9 4.0 
Height (m) 3108 1.68 0.09 
Alcohol intake (gr/d) 3108 2.8 4.0 
Energy intake (Kcal/d) 3108 1640.1 594.5 
Age at recruitment (years) 3108 60.3 1.1 
Age at exit from follow-up (years) 3108 73.6 3.1 
 
 
 
 
 
 
Categorical variables 
 
Descriptive statistics for categorical variables (overall) 
  
 
  all excluding missing 
 
  
 
n % 
 
n % 
Education none or less than primary 
 
0 0.0 
 
0 0.0 
 
primary 
 
1839 55.1 
 
1695 54.5 
 
vocational or technical secondary 
 
839 25.2 
 
787 25.3 
 
secondary not vocational/technical 
 
267 8.0 
 
259 8.3 
  college or university 
 
390 11.7 
 
367 11.8 
Living alone no 
 
2612 78.7 
 
2449 78.8 
 
yes 
 
706 21.3 
 
659 21.2 
Employment  employed, not of pensionable age 
 
1818 54.0 
 
1705 54.9 
status self-employed 
 
288 8.6 
 
265 8.5 
 
housewife  
 
124 3.7 
 
110 3.5 
 
pensionable age, working 
 
0 0.0 
 
0 0.0 
 
pensionable age, not working 
 
882 26.2 
 
816 26.3 
 
not working due to poor health 
 
0 0.0 
 
0 0.0 
  unemployed-not of pensionable age 
 
252 7.5 
 
212 6.8 
Smoking 
status never 
 
2007 61.2 
 
1891 60.8 
 
former 
 
719 21.9 
 
686 22.1 
 
current 
 
552 16.8 
 
531 17.1 
Hypertension no 
 
2298 68.3 
 
2127 68.4 
  yes 
 
1066 31.7 
 
981 31.6 
Prevalent  no 
 
3175 94.4 
 
2932 94.3 
cancer yes 
 
189 5.6 
 
176 5.7 
Prevalent no 
 
3233 97.0 
 
3013 96.9 
 diabetes yes 
 
101 3.0 
 
95 3.1 
Prevalent no 
 
3268 97.1 
 
3016 97.0 
CVD yes 
 
96 2.9 
 
92 3.0 
Mortality alive 
 
2862 85.1 
 
2648 85.2 
Status dead 
 
502 14.9 
 
460 14.8 
Incident Hip  no 
 
3295 97.9 
 
3044 97.9 
Fractures yes 
 
69 2.1 
 
64 2.1 
 
 
 
 
 
 
 
 
The Nurses' Health Study (NHS) 
The NHS started in 1976 when 121701 married female registered nurses, aged 30–55 
years, residents in 11 US states, responded to initial mailed questionnaire collecting 
information on lifestyle practices, medical history, and risk factors related to cancer 
and other health outcomes [3]. Follow-up questionnaires were sent every 2 years in 
order to update individual characteristics and to identify incident diseases. The NHS 
was approved by the Institutional Review Board of the Brigham and Women’s 
Hospital.  
 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
Continuous variables 
 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 103282 26.7 5.3 
Height (m) 121326 1.64 0.06 
Alcohol intake (gr/d) 94478 5.9 10.4 
Energy intake (Kcal/d) 94478 1734.2 533.1 
Age at recruitment (years) 121550 61.0 0.7 
Age at exit from follow-up (years) 116308 75.2 7.0 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 68468 26.8 5.4 
Height (m) 68468 1.64 0.06 
Alcohol intake (gr/d) 68468 5.8 10.1 
Energy intake (Kcal/d) 68468 1757.5 529.2 
Age at recruitment (years) 68468 61.0 0.6 
Age at exit from follow-up (years) 68468 74.1 6.1 
 
 
Categorical variables 
 
 
Descriptive statistics for categorical variables (overall) 
  
 
  all excluding missing 
 
  
 
n % 
 
n % 
Vigorous 
Physical  no 
 
81850 77.6 
 
47469 69.3 
Activity yes 
 
23581 22.4 
 
20999 30.7 
Living alone no 
 
81430 67.0 
 
59194 86.5 
 
yes 
 
40120 33.0 
 
9274 13.5 
Employment  employed, not of pensionable age 
 
56548 64.4 
 
44538 65.0 
Status self-employed 
 
0 0.0 
 
0 0.0 
 
housewife  
 
20202 23.0 
 
13992 20.4 
 
pensionable age, working 
 
0 0.0 
 
0 0.0 
 
pensionable age, not working 
 
11011 12.5 
 
9938 14.5 
 
not working due to poor health 
 
0 0.0 
 
0 0.0 
  unemployed-not of pensionable age 
 
0 0.0 
 
0 0.0 
Smoking  never 
 
49971 44.6 
 
29894 43.7 
status former 
 
44965 40.1 
 
29486 43.1 
 
current 
 
17164 15.3 
 
9088 13.3 
Hypertension no 
 
74194 61.0 
 
40653 59.4 
  yes 
 
47356 39.0 
 
27815 40.6 
Mortality alive 
 
91943 79.1 
 
58342 85.2 
Status dead 
 
24365 20.8 
 
10126 14.8 
Prevalent  no 
 
112822 92.8 
 
63726 93.1 
Diabetes yes 
 
8728 7.2 
 
4742 6.9 
Prevalent  no 
 
116922 96.2 
 
65984 96.4 
CVD yes 
 
4628 3.8 
 
2484 3.6 
Prevalent  no 
 
107166 88.2 
 
60497 88.4 
Cancer yes 
 
14384 11.8 
 
7971 11.6 
Incident Hip  no 
 
118883 97.8 
 
67208 98.2 
Fractures yes 
 
2667 2.2 
 
1260 1.8 
 
 
 
 
 
 
 
The Tromsø Study 
The Tromsø Study is a repeated population-based health survey of inhabitants in the 
municipality of Tromsø in Norway [4]. The examinations were repeated in 1974 
(Tromsø 1), 1979–80 (Tromsø 2), 1986–87 (Tromsø 3), 1994–95 (Tromsø 4), 2001 
(Tromsø 5) and 2007–08 (Tromsø 6). In all surveys, the participants completed self-
administered questionnaires covering a wide range of variables of interest.Mortality 
was assessed until the end of 2009 for this study, via record linkage to Statistics 
Norway [5,6]. Since Tromsø 4 and thereafter, the fracture registry was initiated. 
 
 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
 
 
Continuous variables 
 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 5825 26.1 4.2 
Height (m) 5826 1.66 0.10 
Age at recruitment (years) 5851 69.9 7.0 
Age at exit from follow-up (years) 5851 81.7 6.4 
 
 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 5373 26.2 4.2 
Height (m) 5373 1.66 0.10 
Age at recruitment (years) 5373 69.6 6.9 
Age at exit from follow-up (years) 5373 81.6 6.4 
 
Categorical variables 
 
  all 
excluding 
missing 
 
  
 
n % 
 
n % 
Vigorous 
Physical  no 
 
4436 76.9 
 
4102 76.3 
activity yes 
 
1332 23.1 
 
1271 23.7 
Education primary or less 
 
3760 64.8 
 
3456 64.3 
 
high school/ lyceum 
 
1473 25.4 
 
1379 25.7 
 
college or university 
 
570 9.8 
 
538 10.0 
Living alone no 
 
3490 59.7 
 
3241 60.3 
 
yes 
 
2354 40.3 
 
2132 39.7 
Employment employed, not of pensionable age 
 
947 16.2 
 
908 16.9 
status self-employed 
 
0 0.0 
 
0 0.0 
 
housewife  
 
473 8.1 
 
441 8.2 
 
pensionable age, working 
 
62 1.1 
 
60 1.1 
 
pensionable age, not working 
 
3313 56.6 
 
2976 55.4 
 
not working due to poor health 
 
578 9.9 
 
535 10.0 
  unemployed-not of pensionable age 
 
478 8.2 
 
453 8.4 
Smoking  never 
 
2111 36.1 
 
1923 35.8 
status former 
 
2184 37.4 
 
2030 37.8 
 
current 
 
1550 26.5 
 
1420 26.4 
Hypertension no 
 
4376 75.2 
 
4017 75.2 
  yes 
 
1442 24.8 
 
1327 24.8 
Prevalent  no 
 
5372 91.8 
 
4941 92.0 
Cancer yes 
 
479 8.2 
 
432 8.0 
Prevalent no 
 
5512 94.7 
 
5105 95.0 
Diabetes  yes 
 
309 5.3 
 
268 5.0 
Prevalent no 
 
4977 85.1 
 
4571 85.1 
CVD yes 
 
874 14.9 
 
802 14.9 
Mortality alive 
 
2704 46.2 
 
2556 47.6 
Status dead 
 
3147 53.8 
 
2817 52.4 
Incident Hip  no 
 
5325 91.0 
 
4995 93.0 
Fractures yes 
 
526 9.0 
 
378 7.0 
 
 
 
 
 
 
 
ESTHER (Epidemiological Study on the Chances of Prevention, Early 
Recognition at Optimised Treatment of Chronic Diseases in the Older 
Population) 
ESTHER Study is a population-based cohort study comprising of 9949 adults, aged 
50–74 years, who were recruited during 2000–2002 from the entire federal state of 
Saarland in Germany [7,8]. Participants were approached during a general health 
check-up at their general practitioner’s office where they completed a detailed self-
administered questionnaire and provided biological samples (blood, stool, urine). 
Until 2012, three re-contacts took place (two, five and eight years after baseline) 
where all participants completed a standardized questionnaire, similar to that at 
baseline. In addition, detailed medical data were obtained from the general 
practitioners, and a comprehensive follow-up with respect to overall and cause-
specific mortality and cancer incidence was conducted through record linkage with 
data from population registries, public health offices and the Saarland Cancer 
Registry.  
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
Continuous variables 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 6536 27.7 4.1 
Height (m) 6540 1.67 0.08 
Alcohol intake (gr/d) 5848 6.6 9.5 
Age at recruitment (years) 6545 66.1 4.1 
Age at exit from follow-up (years) 6544 76.9 4.5 
 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 4957 27.7 4.1 
Height (m) 4957 1.67 0.08 
Alcohol intake (gr/d) 4957 6.8 9.7 
Age at recruitment (years) 4957 65.9 4.1 
Age at exit from follow-up (years) 4957 76.7 4.4 
 
Categorical variables 
 
  all excluding missing 
 
  
 
n % 
 
n % 
Vigorous 
Physical  no 
 
4126 63.32 
 
2941 59.3 
activity yes 
 
2390 36.68 
 
2016 40.7 
Education none or less than primary 
 
232 3.658 
 
158 3.2 
 
primary 
 
4717 74.38 
 
3588 72.4 
 
vocational or technical secondary 
 
1140 17.98 
 
991 20.0 
 
secondary not vocational/technical 
 
253 3.989 
 
220 4.4 
  college or university 
 
0 0 
 
0 0 
Living alone no 
 
4769 74.23 
 
3730 75.2 
 
yes 
 
1656 25.77 
 
1227 24.8 
Employment  employed, not of pensionable age 
 
371 5.897 
 
302 6.1 
Status self-employed 
 
47 0.747 
 
36 0.7 
 
housewife  
 
751 11.94 
 
574 11.6 
 
pensionable age, working 
 
153 2.432 
 
108 2.2 
 
pensionable age, not working 
 
3504 55.7 
 
2722 54.9 
 
not working due to poor health 
 
1438 22.86 
 
1190 24.0 
  unemployed-not of pensionable age 
 
27 0.429 
 
25 0.5 
Smoking status never 
 
3412 54 
 
2579 52.0 
 
former 
 
2104 33.3 
 
1741 35.1 
 
current 
 
803 12.71 
 
637 12.9 
Hypertension no 
 
2439 37.27 
 
1789 36.1 
  yes 
 
4106 62.73 
 
3168 63.9 
Prevalent  no 
 
6063 92.64 
 
4585 92.5 
cancer yes 
 
482 7.364 
 
372 7.5 
Prevalent  no 
 
5288 86.55 
 
4348 87.7 
Diabetes yes 
 
822 13.45 
 
609 12.3 
Prevalent  no 
 
5628 89.62 
 
4456 89.9 
CVD yes 
 
652 10.38 
 
501 10.1 
Mortality alive 
 
5229 79.89 
 
4001 80.7 
Status dead 
 
1316 20.11 
 
956 19.3 
Incident Hip  no 
 
6456 98.6 
 
4895 98.7 
Fractures yes 
 
89 1.4 
 
62 1.3 
The Swedish Mammography Cohort (SMC) and the Cohort Of Swedish Men 
(COSM) 
 
Two population-based prospective cohort studies provided data for the present 
analyses. The SMC was established between 1987 and 1990, when all women born 
between 1914 and 1948 and living in central Sweden received a mailed questionnaire 
that elicited information on diet, weight, height and education; 66651 women returned 
a completed questionnaire. In 1997, an expanded questionnaire that included data on 
various lifestyle factors and medical history was mailed to women who were still 
alive and residing in the study area; 39227 women (70%) completed the 
questionnaire. At the same time, 48850 men born between 1918 and 1952 and 
residing in central Sweden were enrolled in the COSM after returning a mailed 
questionnaire that was identical to the 1997 SMC questionnaire (except for some sex-
specific questions). The studies were approved by the Regional Ethical Review Board 
in Stockholm [9]. 
 
COSM 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
Continuous variables 
All participants (Initial Sample) 
Variable name n mean sd 
BMI (kg/m2) 19815 25.7 3.4 
Height (m) 19955 1.76 0.07 
Alcohol intake (gr/d) 19581 10.8 12.5 
Energy intake (Kcal/d) 21072 2408.8 739.6 
Age at recruitment (years) 21433 69.4 5.2 
Age at exit from follow-up (years) 21433 81.7 5.4 
 All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 15744 25.7 3.2 
Height (m) 15744 1.76 0.07 
Alcohol intake (gr/d) 15744 11.1 12.4 
Energy intake (Kcal/d) 15744 2466.3 692.5 
Age at recruitment (years) 15744 69.0 5.2 
Age at exit from follow-up (years) 15744 81.7 5.4 
 
 
Categorical Variables 
 
  
all 
excluding 
missing 
 
   
n % 
 
n % 
Vigorous Physical  no  
1187 6.2 
 
878 5.6 
Activity yes  
17876 93.8 
 
14866 94.4 
Education none or less than primary  
0 0.0 
 
0 0.0 
 
primary  
10188 47.9 
 
6960 44.2 
 
vocational or technical secondary  
8867 41.7 
 
6906 43.9 
 
secondary not vocational/technical  
593 2.8 
 
474 3.0 
  college or university  
1638 7.7 
 
1404 8.9 
Living alone no  
17206 80.3 
 
13122 83.3 
 
yes  
4227 19.7 
 
2622 16.7 
Employment  Employed, not of pensionable age  
2663 12.5 
 
2201 14.0 
Status self-employed  
7 0.0 
 
7 0.0 
 
housewife   
0 0.0 
 
0 0.0 
 
pensionable age, working  
0 0.0 
 
0 0.0 
 
pensionable age, not working  
17217 80.8 
 
12497 79.4 
 
not working due to poor health  
1027 4.8 
 
725 4.6 
  unemployed-not of pensionable age  
407 1.9 
 
314 2.0 
Smoking status never  
7754 36.8 
 
5948 37.8 
 
former  
8469 40.2 
 
6483 41.2 
 
current  
4832 22.9 
 
3313 21.0 
Hypertension no  
14338 66.9 
 
10726 68.1 
  yes  
7095 33.1 
 
5018 31.9 
Mortality alive  
10936 51.0 
 
8601 54.6 
Status dead  
10497 49.0 
 
7143 45.4 
Prevalent  no  
19458 90.8 
 
14400 91.5 
Diabetes yes  
1975 9.2 
 
1344 8.5 
Prevalent  no  
17388 81.1 
 
12932 82.1 
CVD yes  
4045 18.9 
 
2812 17.9 
Incident Hip  no 
 
20.087 93.7 
 
14.808 94.1 
Fractures yes 
 
1.346 6.3 
 
936 5.9 
 
SMC 
Below, we present the descriptive characteristics for categorical and continuous 
variables for all participants and those finally analyzed (after excluding missing 
values) 
 
Continuous variables 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 19043 25.3 4.0 
Height (m) 17299 1.64 0.06 
Alcohol intake (gr/d) 17158 4.0 6.2 
Energy intake (Kcal/d) 19542 1665.2 557.5 
Age at recruitment (years) 19591 70.0 5.9 
Age at exit from follow-up (years) 19591 83.2 5.7 
 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 12923 25.2 3.9 
Height (m) 12923 1.64 0.06 
Alcohol intake (gr/d) 12923 4.4 6.4 
Energy intake (Kcal/d) 12923 1713.1 510.9 
Age at recruitment (years) 12923 69.0 5.6 
Age at exit from follow-up (years) 12923 82.7 5.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Categorical variables 
  
Initial Sample excluding missing 
  
  n %  
n % 
Vigorous 
Physical  no  
1122 6.8 
 
777 6.0 
activity yes  
15337 93.2 
 
12146 94.0 
Education none or less than primary  
0 0.0 
 
0 0.0 
 
primary  
10802 55.8 
 
6518 50.4 
 
vocational or technical secondary  
7217 37.3 
 
5279 40.8 
 
secondary not vocational/technical  
226 1.2 
 
169 1.3 
  college or university  
1124 5.8 
 
957 7.4 
Prevalent  no  
18390 93.9 
 
12172 94.2 
Cancer yes  
1201 6.1 
 
751 5.8 
Employment  employed, not of pensionable age  
2022 10.4 
 
1638 12.7 
Status self-employed  
0 0.0 
 
0 0.0 
 
housewife   
892 4.6 
 
523 4.0 
 
pensionable age, working  
0 0.0 
 
0 0.0 
 
pensionable age, not working  
15093 77.7 
 
9752 75.5 
 
not working due to poor health  
1190 6.1 
 
832 6.4 
  unemployed-not of pensionable age  
230 1.2 
 
178 1.4 
Smoking 
status never  
12407 65.0 
 
8222 63.6 
 
former  
3331 17.4 
 
2470 19.1 
 
current  
3354 17.6 
 
2231 17.3 
Hypertension no  
14251 72.7 
 
9410 72.8 
  yes  
5340 27.3 
 
3513 27.2 
Mortality alive  
12068 61.6 
 
8732 67.6 
Status dead  
7523 38.4 
 
4191 32.4 
Prevalent  no  
18404 93.9 
 
12260 94.9 
Diabetes yes  
1187 6.1 
 
663 5.1 
Prevalent no  
17836 91.0 
 
11946 92.4 
CVD yes  
1755 9.0 
 
977 7.6 
Incident Hip  no 
 
17319 88.4 
 
11596 89.7 
Fractures yes 
 
2272 11.6 
 
1327 10.3 
 
 
 
 
 
 
 
 
 The Health, Alcohol and Psychosocial factors in Eastern Europe (HAPPIE) 
study with data from the Czech Republic 
The multi-centre study HAPIEE study assessing the effects of dietary factors, alcohol 
consumption and psychosocial factors on health is being conducted in random 
samples of men and women selected in Russia, Poland, Lithuania and the Czech 
Republic - four countries of Central and Eastern Europe undergoing rapid social and 
economic transition [10]. Below, we present the descriptive characteristics for 
categorical and continuous variables for all participants and those finally analyzed 
(after excluding missing values) 
 
Continuous variables 
 
All participants (Initial Sample) 
Variable name n mean  sd 
BMI (kg/m2) 3825 24.3 11.3 
Height (m) 3828 1.67 0.09 
Alcohol intake (gr/d) 3745 13.4 21.8 
Energy intake (Kcal/d) 3810 2036.9 1020.8 
Age at recruitment (years) 3833 64.8 2.9 
Age at exit from follow-up (years) 3694 72.6 3.2 
 
 
 
All participants (excluding missing values) 
Variable name n mean  sd 
BMI (kg/m2) 3198 25.0 10.6 
Height (m) 3198 1.67 0.09 
Alcohol intake (gr/d) 3198 13.6 21.9 
Energy intake (Kcal/d) 3198 2029.8 965.6 
Age at recruitment (years) 3198 64.7 2.9 
Age at exit from follow-up (years) 3198 72.6 3.2 
 
 
 
 
 Categorical variables 
 
  all excluding missing 
 
   
n % 
 
n % 
Vigorous 
Physical  no  
1148 31.5 
 
990 31.0 
activity yes  
2492 68.5 
 
2208 69.0 
Education none or less than primary  
26 0.7 
 
19 0.6 
 
primary  
568 14.9 
 
456 14.3 
 
vocational or technical secondary  
1378 36.2 
 
1153 36.1 
 
secondary not vocational/technical  
1328 34.9 
 
1135 35.5 
  college or university  
502 13.2 
 
435 13.6 
Living alone no  
2836 74.2 
 
2401 75.1 
 
yes  
984 25.8 
 
797 24.9 
Employment  employed, not of pensionable age  
155 4.1 
 
138 4.3 
status self-employed  
82 2.2 
 
72 2.3 
 
housewife   
12 0.3 
 
10 0.3 
 
pensionable age, working  
545 14.4 
 
474 14.8 
 
pensionable age, not working  
2979 78.7 
 
2494 78.0 
 
not working due to poor health  
1 0.0 
 
1 0.0 
 
unemployed-not of pensionable age  
10 0.3 
 
8 0.3 
  employed, not of pensionable age  
3 0.1 
 
1 0.0 
Smoking  never  
1856 49.1 
 
1556 48.7 
status former  
1219 32.3 
 
1029 32.2 
 
current  
704 18.6 
 
613 19.2 
Hypertension no  
1640 43.0 
 
1390 43.5 
  yes  
2178 57.0 
 
1808 56.5 
Prevalent  no  
3562 92.9 
 
2979 93.2 
Cancer yes  
271 7.1 
 
219 6.8 
Prevalent  no  
3157 82.7 
 
2656 83.1 
Diabetes yes  
661 17.3 
 
542 16.9 
Prevalent  no  
3156 88.0 
 
2822 88.2 
CVD yes  
430 12.0 
 
376 11.8 
Mortality alive  
3207 86.8 
 
2799 87.5 
Status dead  
487 13.2 
 
399 12.5 
Incident Hip  no 
 
3789 98.9 
 
3161 98.8 
Fractures yes 
 
44 1.2 
 
37 1.2 
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Fig 1 Forest plot showing hazard ratios for mortality after hip fracture in model 3 (i.e. the fully adjusted model). 
 
Fig. 2 Forest plot showing relative excess risk due to interaction (RERI) between hip fractures and chronic diseases for mortality in model 3 (i.e. 
the fully adjusted model). 
 
Table 1 Description of the participating cohorts  
 
Cohort name Country na Females, n (%) Hip fractures, n (%) Deaths, n (%) Mean age 
(years) at 
enrolment (SD) 
Baseline 
period 
Mean follow-up 
period (years)  
(SD) 
EPIC-Greece Greece 9037 5488 (61) 209 (2) 1907 (21) 67.3 (4.5) 1994–1999 10.3 (3.3) 
EPIC-Sweden Sweden 3108 1641 (53) 64 (2) 460 (15) 60.3 (1.1) 1992–1996 13.3 (3.0) 
Nurses’ Health Study USA 68,468 68,468 (100) 1260 (2) 10,126 (15) 61.0 (0.6) 1986–2010 13.0 (6.1) 
The Tromsø study Norway 5373 2930 (55) 378 (7) 2817 (52) 69.6 (6.9) 1994–1995 12.0 (4.9) 
ESTHER Germany 4957 2541 (51) 62 (1) 956 (19) 65.9 (4.1) 2000–2002 10.8 (2.4) 
COSM Sweden 15,744 0 (0) 936 (6) 7143 (45) 69.0 (5.2) 1998 12.7 (4.1) 
SMC Sweden 12,923 12,923 (100) 1327 (10) 4191 (32) 69.0 (5.6) 1998 13.7 (3.5) 
HAPIEE Czech Republic 3198 1649 (52) 37 (1) 399 (13) 64.7 (2.9) 2002–2005 7.9 (1.6) 
 
aNumber of participants (without missing values for any confounding variable included in model 3). 
 
 
 
 
 
 
 
Table 2A Characteristics of male participants at baseline by participating cohort (based on the number of observations in the fully adjusted 
model 3) 
 
 EPIC-
Greece 
EPIC-
Sweden 
Nurses’ 
Health Study 
Tromsø 
study 
ESTHER COSM SMC HAPIEE-
Czech 
Men, n (%) 3549 (39) 1467 (47) 0 (0) 2443 (45) 2416 (49) 15,744 (100) 0 (0) 1549 (48) 
         
Body mass index (kg/m2), mean (SD) 28.0 (4.0) 25.9 (3.6) - 25.8 (3.5) 27.8 (3.8) 25.7 (3.2) - 24.6 (10.6) 
Height (m), mean (SD) 1.66 (0.06) 1.75 (0.06) - 1.74 (0.07) 1.73 (0.06) 1.76 (0.06) - 1.74 (0.06) 
Energy intake (kcal/day), mean (SD) 2049 (613) 1916 (636) - - - 2466 (692) - 2051 (964) 
Alcohol intake (g/day), mean (SD) 15.2 (23.3) 4.3 (5.0) - - 10.2 (11.6) 11.1 (12.4) - 23.3 (27.0) 
Education (primary or less), n (%) 3209 (90) 789 (54) - 1319 (54) 1744 (72) 6960 (44) - 108 (7) 
Living alone, n (%) 231 (7) 270 (18) - 642 (26) 310 (13) 2622 (17) - 202 (13) 
Currently working, n (%) 980 (28) 884 (60) - 540 (22) 205 (8) 2208 (14) - 441 (29) 
Never smokers, n (%) 1131 (32) 756 (52) - 370 (15) 759 (31) 5948 (38) - 519 (34) 
Vigorous physical activity, n (%) 686 (19) - - 813 (33) 1159 (48) 14,866 (94) - 1077 (70) 
Hypertension, n (%) 1432 (40) 423 (29) - 569 (23) 1594 (66) 5018 (32) - 894 (58) 
Prevalent cancer, n (%) 102 (3) 42 (3) - 201 (8) 165 (7) - - 86 (6) 
Prevalent diabetes, n (%) 551 (16) 64 (4) - 108 (4) 346 (14) 1344 (9) - 302 (19) 
Prevalent CVD, n (%) 384 (11) 76 (5) - 503 (21) 356 (15) 2812 (18) - 255 (16) 
 
 
 
 
 
Table 2B Characteristics of female participants at baseline by participating cohort (based on the number of observations in the fully adjusted 
model 3) 
 EPIC-
Greece 
EPIC-
Sweden 
Nurses’ 
Health Study 
Tromsø 
study 
ESTHER COSM SMC HAPIEE-
Czech 
Women; n (%) 5488 (61) 1641 (53) 68,468 (100) 2930 (55) 2541 (51) 0 (0) 12,923 (100) 1649 (52) 
        - 
Body mass index (kg/m2), mean (SD) 30.1 (4.8) 25.9 (4.4) 26.8 (5.4) 26.5 (4.7) 27.5 (4.3) - 25.2 (3.9) 25.3 (10.7) 
Height (m), mean (SD) 1.53 (0.06) 1.62 (0.06) 1.64 (0.06) 1.59 (0.06) 1.62 (0.06) - 1.64 (0.06) 1.61 (0.06) 
Energy intake (kcal/day), mean (SD) 1648 (500) 1393 (423) 1758 (529) - - - 1713 (511) 2010 (967) 
Alcohol intake (g/day), mean (SD) 2.5 (5.4) 1.4 (2.2) 5.8 (10.1) - 3.5 (5.7) - 4.4 (6.4) 4.6 (8.6) 
Education (primary or less), n (%) 5064 (92) 906 (55) - 2137 (73) 2002 (79) - 6518 (50) 367 (22) 
Living alone, n (%) 1599 (29) 389 (24) 9274 (14) 1490 (51) 917 (36) - - 595 (36) 
Currently working, n (%) 669 (12) 1086 (66) 44,538 (65) 428 (15) 241 (9) - 1638 (13) 243 (15) 
Never smokers, n (%) 5151 (94) 1135 (69) 29,894 (44) 1553 (53) 1820 (72) - 8222 (64) 1037 (63) 
Vigorous physical activity, n (%) 1179 (21) - 20,999 (31) 458 (16) 857 (34) - 12,146 (94) 1131 (69) 
Hypertension, n (%) 2710 (49) 558 (34) 27,815 (41) 758 (26) 1574 (62) - 3513 (27) 914 (55) 
Prevalent cancer, n (%) 218 (4) 134 (8) 7971 (12) 231 (8) 207 (8) - 751 (6) 133 (8) 
Prevalent diabetes, n (%) 766 (14) 31 (2) 4742 (7) 160 (5) 263 (10) - 663 (5) 240 (15) 
Prevalent CVD, n (%) 209 (4) 16 (1) 2484 (4) 299 (10) 145 (6) - 977 (8) 121 (7) 
 
 
 
 
 
Table 3 Hazard ratio (HR) for mortality (95% confidence interval) after hip fracture among participants in three models 
 
 Number of 
cohorts 
HR from 
model 1a 
 
HR from 
model 2b 
HR from 
model 3c 
I2 for model 3 (P-value) 
Total population  8 2.39 (1.95–2.92) 2.21 (1.82–2.68) 2.12 (1.76–2.57) 90% (<0.001) 
      
Men  6 2.87 (1.90–4.35) 2.54 (1.78–3.62) 2.39 (1.72–3.31) 78% (<0.001) 
Women  7 2.07 (1.67–2.56) 1.97 (1.59–2.44) 1.92 (1.54–2.39) 84% (<0.001) 
      
Elderly (≥70 years at baseline) 5 1.91 (1.49–2.45) 1.88 (1.49–2.38) 1.84 (1.46–2.33) 90% (<0.001) 
 
aModel 1: adjusted for age (in years; continuous) and sex (male/female). 
bModel 2: adjusted for the same variables as in model 1 and additionally for the continuous variables body mass index (in kg/m2) , height (in m), daily energy intake (in 
kcal/day) and alcohol intake (in g/day),  and the categorical variables vigorous physical activity (yes/no), educational level (none/less than primary/vocational or technical 
secondary/secondary, not vocational and not technical/college or university), living alone (yes/no), employment status (full-time or part-time employment and not of 
pensionable age/self-employment/housewife and not of pensionable age/pensionable age and still working/pensionable age and not working/stopped working before 
retirement age due to poor health/unemployed and not of pensionable age) and smoking status (never/former/current smoker). 
 
cModel 3: adjusted for the same variables as in model 2 and additionally hypertension (yes/no) and chronic diseases (cardiovascular disease, diabetes or cancer; yes/no). 
 
 
 
 
Table 4 Hazard ratio (HR) and 95% confidence interval (CI) for mortality after hip fracture in model 3 (i.e. the fully adjusted model) by time 
since fracture occurrence  
Time since hip fracture Number 
of cohorts 
HR for 
model 3a 
95% CI I2 for model 3 
(P-value) 
≥0 to <1 year  8 2.78 2.12–3.64 81% (<0.001) 
≥1 to <4 years 8 1.89 1.50–2.37 81% (<0.001) 
≥4 to <8 years 8 2.15 1.81–2.55 57% (0.021) 
≥8 years 7 1.79 1.57–2.05 0% (0.918) 
 
aModel 3 adjusted for sex (male/female), the continuous variables age (in years), body mass index (in kg/m2), height (in m), daily energy intake (in kcal/day) and alcohol 
intake (in g/day) and the categorical variables vigorous physical activity (yes/no), educational level (none/less than primary/vocational or technical secondary/secondary, not 
vocational and not technical/college or university), living alone (yes/no), employment status (full-time or part-time employment and not of pensionable age/self-
employment/housewife and not of pensionable age/pensionable age and still working/pensionable age and not working/stopped working before retirement age due to poor 
health/unemployed and not of pensionable age) and smoking status (never/former/current smoker), and hypertension (yes/no) and chronic diseases (cardiovascular disease, 
diabetes or cancer; yes/no). 
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